The fact that genetic deletion of either CCR5 or CXCR6 abrogated the therapeutic effect of ICB underscores that the coordinated function of all three receptors on the R6R3R5 subset is non-redundant and essential for a successful anti-tumor response. This evidence concerns the gene CXCR6 and neoplasm.